|
When a drug is a mere twinkle in a scientist's eye, Compugen is there. The Israeli drug discovery company uses its expertise in computer sciences and molecular biology to predict molecular behavior and discover potential therapies and diagnostic biomarkers. It then licenses those discoveries -- focused mainly in the areas of cancer, cardiovascular disease, and immune disorders -- to other drug firms for further development, in return for milestone payments and future royalties. Compugen has formed licensing and collaboration partnerships with numerous companies, including Biosite, Medarex, Ortho-Clinical Diagnostics, and Roche.
|
| | | Contact Information | |
Address: |
72 Pinchas Rosen St.
Tel Aviv 69512, Israel
| | Phone: | +972-3-765-8585 | | Fax: | +972-3-765-8555 |
|
| Financial
Highlights | | Fiscal Year End: | December | | Revenue (2008): | 0.30 M | | Revenue Growth (1 yr): | 87.80% | | Employees (2008): | 57 | | Employee Growth (1 yr): | (-20.80%) |
|
|
Key People
| | • |
Chairman:
Dov Hershberg
| | • |
Co-CEO:
Martin S. Gerstel
| | • |
Co-CEO:
Anat Cohen-Dayag
|
|
|
